請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28581
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳青周(Ching-Chow Chen) | |
dc.contributor.author | Chun-Wei Chang | en |
dc.contributor.author | 張峻瑋 | zh_TW |
dc.date.accessioned | 2021-06-13T00:12:56Z | - |
dc.date.available | 2007-08-08 | |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-27 | |
dc.identifier.citation | Albanese, C. 2003. IKK[alpha] regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol Biol Cell 14: 585-599.
Baldwin, A.S. 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107(3): 241-246. Barnes, P.J. and Karin, M. 1997. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336(15): 1066-1071. Bonizzi, G. and Karin, M. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25(6): 280-288. Broemer, M., Krappmann, D., and Scheidereit, C. 2004. Oncogene 23: 5378-5386. Carayol, N. and Wang, C.Y. 2006. IKK[alpha] stabilizes cytosolic [beta]-catenin by inhibiting both canonical and non-canonical degradation pathways. Cell Signal 18: 1941-1946. Chen, G., Cao, P., and Goeddel, D.V. 2002. Mol Cell 9: 401-410. Chen, Z.J. 2005. Ubiquitin signalling in the NF-[kappa]B pathway. Nature Cell Biol 7: 758-765. Chen, Z.J., Parent, L., and Maniatis, T. 1996. Site-specific phosphorylation of I[kappa]B[alpha] by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862. Cohen, S., Achbert-Weiner, H., and Ciechanover, A. 2004. Dual effects of I[kappa]B kinase [beta]-mediated phosphorylation on p105 fate: SCF([beta]-TrCP)-dependent degradation and SCF([beta]-TrCP)-independent processing. Mol Cell Biol 24: 475-486. Coussens, L.M. and Werb, Z. 2002. Inflammation and cancer. Nature 420(6917): 860-867. Dejardin, E. 2006. The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol 72(9): 1161-1179. Dejardin, E., Droin, N.M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z.W., Karin, M., Ware, C.F., and Green, D.R. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17(4): 525-535. Delhase, M., Hayakawa, M., Chen, Y., and Karin, M. 1999. Science 284: 309-313. Deng, J., Miller, S.A., Wang, H.Y., Xia, W., Wen, Y., Zhou, B.P., Li, Y., Lin, S.Y., and Hung, M.C. 2002. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2(4): 323-334. Draghici, S., Khatri, P., Eklund, A.C., and Szallasi, Z. 2006. Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 22(2): 101-109. Fontan, E., Traincard, F., Levy, S.G., Yamaoka, S., Veron, M., and Agou, F. 2007. NEMO oligomerization in the dynamic assembly of the IkappaB kinase core complex. Febs J. Ge, X., Jung, Y.C., Wu, Q., Kibbe, W.A., and Wang, S.M. 2006. Annotating nonspecific SAGE tags with microarray data. Genomics 87(1): 173-180. Gerondakis, S., Grumont, R., Gugasyan, R., Wong, L., Isomura, I., Ho, W., and Banerjee, A. 2006. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 25(51): 6781-6799. Gilmore, T.D. and Herscovitch, M. 2006. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25(51): 6887-6899. Gloire, G., Horion, J., El Mjiyad, N., Bex, F., Chariot, A., Dejardin, E., and Piette, J. 2007. Promoter-dependent Effect of IKK{alpha} on NF-{kappa}B/p65 DNA Binding. J Biol Chem 282(29): 21308-21318. Hanahan, D. and Weinberg, R.A. 2000. The hallmarks of cancer. Cell 100(1): 57-70. Hayden, M.S. and Ghosh, S. 2004a. Signaling to NF-[kappa]B. Genes Dev 18: 2195-2224. Hoberg, J.E., Yeung, F., and Mayo, M.W. 2004. SMRT derepression by the I[kappa]B kinase [alpha]: a prerequisite to NF-[kappa]B transcription and survival. Mol Cell 16: 245-255. Hu, M.C., Lee, D.F., Xia, W., Golfman, L.S., Ou-Yang, F., Yang, J.Y., Zou, Y., Bao, S., Hanada, N., Saso, H., Kobayashi, R., and Hung, M.C. 2004. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117(2): 225-237. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. 1999. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284(5412): 316-320. Huang, W.-C., Chan, S.-T., Yang, T.-L., Tzeng, C.-C., and Chen, C.-C. 2004. Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel {alpha}-methylene-{gamma}-butyrolactone derivatives. Carcinogenesis 25(10): 1925-1934. Huang, W.C., Ju, T.K., Hung, M.C., and Chen, C.C. 2007. Phosphorylation of CBP by IKKalpha Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-kappaB. Mol Cell 26(1): 75-87. Hudson, J.D., Shoaibi, M.A., Maestro, R., Carnero, A., Hannon, G.J., and Beach, D.H. 1999. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190(10): 1375-1382. Janssens, S. and Tschopp, J. 2006. Signals from within: the DNA-damage-induced NF-[kappa]B response. Cell Death Differ 13: 773-784. Jung, Y.J., Isaacs, J.S., Lee, S., Trepel, J., and Neckers, L. 2003. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. Faseb J 17(14): 2115-2117. Kaisho, T., Takeda, K., Tsujimura, T., Kawai, T., Nomura, F., Terada, N., and Akira, S. 2001. IkappaB kinase alpha is essential for mature B cell development and function. J Exp Med 193(4): 417-426. Karin, M. 1999. Oncogene 18: 6867-6874. Karin, M., Cao, Y., Greten, F.R., and Li, Z.W. 2002. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2(4): 301-310. Karin, M. and Greten, F.R. 2005. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10): 749-759. Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., and French, D.M. 2002. Immunity 17: 515-524. Kodzius, R., Kojima, M., Nishiyori, H., Nakamura, M., Fukuda, S., Tagami, M., Sasaki, D., Imamura, K., Kai, C., Harbers, M., Hayashizaki, Y., and Carninci, P. 2006. CAGE: cap analysis of gene expression. Nat Methods 3(3): 211-222. Krappmann, D. and Scheidereit, C. 2005. A pervasive role of ubiquitin conjugation in activation and termination of I[kappa]B kinase pathways. EMBO Rep 6: 321-326. Lamberti, C. 2001. Regulation of [beta]-catenin function by the I[kappa]B kinases. J Biol Chem 276: 42276-42286. Lapidot, M. and Pilpel, Y. 2006. Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms. EMBO Rep 7(12): 1216-1222. Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V., and Karin, M. 2005. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434(7037): 1138-1143. Lee, H., Arsura, M., Wu, M., Duyao, M., Buckler, A.J., and Sonenshein, G.E. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J Exp Med 181(3): 1169-1177. Liu, B., Yang, Y., Chernishof, V., Loo, R.R.O., Jang, H., Tahk, S., Yang, R., Mink, S., Shultz, D., Bellone, C.J., Loo, J.A., and Shuai, K. 2007. Proinflammatory Stimuli Induce IKK[alpha]-Mediated Phosphorylation of PIAS1 to Restrict Inflammation and Immunity. Cell 129(5): 903-914. Luo, J.L., Tan, W., Ricono, J.M., Korchynskyi, O., Zhang, M., Gonias, S.L., Cheresh, D.A., and Karin, M. 2007. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446(7136): 690-694. Malek, S., Chen, Y., Huxford, T., and Ghosh, G. 2001. IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells. J Biol Chem 276(48): 45225-45235. Matsumura, H., Reich, S., Ito, A., Saitoh, H., Kamoun, S., Winter, P., Kahl, G., Reuter, M., Kruger, D.H., and Terauchi, R. 2003. Gene expression analysis of plant host-pathogen interactions by SuperSAGE. Proc Natl Acad Sci U S A 100(26): 15718-15723. Mercurio, F., Murray, B.W., Shevchenko, A., Bennett, B.L., Young, D.B., and Li, J.W. 1999. Mol Cell Biol 19: 1526-1538. Naumann, M., Nieters, A., Hatada, E.N., and Scheidereit, C. 1993. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors. Oncogene 8(8): 2275-2281. Ng, P., Wei, C.L., Sung, W.K., Chiu, K.P., Lipovich, L., Ang, C.C., Gupta, S., Shahab, A., Ridwan, A., Wong, C.H., Liu, E.T., and Ruan, Y. 2005. Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation. Nat Methods 2(2): 105-111. Novack, D.V., Yin, L., Hagen-Stapleton, A., Schreiber, R.D., Goeddel, D.V., and Ross, F.P. 2003. J Exp Med 198: 771-781. Park, K.J., Krishnan, V., O'Malley, B.W., Yamamoto, Y., and Gaynor, R.B. 2005. Formation of an IKK[alpha]-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 18: 71-82. Pasparakis, M., Luedde, T., and Schmidt-Supprian, M. 2006. Dissection of the NF-[kappa]B signalling cascade in transgenic and knockout mice. Cell Death Differ 13: 861-872. Pasparakis, M., Schmidt-Supprian, M., and Rajewsky, K. 2002. IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med 196(6): 743-752. Perkins, N.D. 2006a. Post-translational modifications regulating the activity and function of the nuclear factor [kappa]B pathway. Oncogene 25: 6717-6730. -. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8(1): 49-62. Pianetti, S., Arsura, M., Romieu-Mourez, R., Coffey, R.J., and Sonenshein, G.E. 2001. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20(11): 1287-1299. Porter, D., Yao, J., and Polyak, K. 2006. SAGE and related approaches for cancer target identification. Drug Discov Today 11(3-4): 110-118. Renu Tuteja, N.T. 2004. Serial analysis of gene expression (SAGE): unraveling the bioinformatics tools. BioEssays 26(8): 916-922. Reuther, J.Y., Reuther, G.W., Cortez, D., Pendergast, A.M., and Baldwin, A.S., Jr. 1998. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev 12(7): 968-981. Rocha, S., Garrett, M.D., Campbell, K.J., Schumm, K., and Perkins, N.D. 2005. Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. Embo J 24(6): 1157-1169. Rocha, S., Martin, A.M., Meek, D.W., and Perkins, N.D. 2003. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-[kappa]B subunit with histone deacetylase 1. Mol Cell Biol 23: 4713-4727. Rothwarf, D.M., Zandi, E., Natoli, G., and Karin, M. 1998. Nature 395: 297-300. Saha, S., Sparks, A.B., Rago, C., Akmaev, V., Wang, C.J., Vogelstein, B., Kinzler, K.W., and Velculescu, V.E. 2002. Using the transcriptome to annotate the genome. Nat Biotechnol 20(5): 508-512. Scheidereit, C. 2006. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 25(51): 6685-6705. Senftleben, U. 2001. Activation by IKK[alpha] of a second, evolutionary conserved, NF-[kappa]B signaling pathway. Science 293: 1495-1499. Shiraki, T., Kondo, S., Katayama, S., Waki, K., Kasukawa, T., Kawaji, H., Kodzius, R., Watahiki, A., Nakamura, M., Arakawa, T., Fukuda, S., Sasaki, D., Podhajska, A., Harbers, M., Kawai, J., Carninci, P., and Hayashizaki, Y. 2003. Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage. Proc Natl Acad Sci U S A 100(26): 15776-15781. Sil, A.K., Maeda, S., Sano, Y., Roop, D.R., and Karin, M. 2004. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428(6983): 660-664. Silva, A.P., De Souza, J.E., Galante, P.A., Riggins, G.J., De Souza, S.J., and Camargo, A.A. 2004. The impact of SNPs on the interpretation of SAGE and MPSS experimental data. Nucleic Acids Res 32(20): 6104-6110. Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., and Akira, S. 1999. Limb and skin abnormalities in mice lacking IKKalpha. Science 284(5412): 313-316. Vakkila, J. and Lotze, M.T. 2004. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4(8): 641-648. Velculescu, V.E., Zhang, L., Vogelstein, B., and Kinzler, K.W. 1995. Serial analysis of gene expression. Science 270(5235): 484-487. Wang, S.M. 2007a. Understanding SAGE data. Trends Genet 23(1): 42-50. Ware, C.F. 2005. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23: 787-819. Westerheide, S.D., Mayo, M.W., Anest, V., Hanson, J.L., and Baldwin, A.S. 2001. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition. Mol Cell Biol 21: 8428-8436. Wu, R.C. 2002. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I[kappa]B kinase. Mol Cell Biol 22: 3549-3561. Wu, Z.H., Shi, Y., Tibbetts, R.S., and Miyamoto, S. 2006a. Molecular linkage between the kinase ATM and NF-[kappa]B signaling in response to genotoxic stimuli. Science 311: 1141-1146. Xiao, G., Harhaj, E.W., and Sun, S.C. 2001. NF-[kappa]B-inducing kinase regulates the processing of NF-[kappa]B2 p100. Mol Cell 7: 401-409. Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K., Saitoh, T., Yamaoka, S., Yamamoto, N., Yamamoto, S., Muta, T., Takeda, K., and Akira, S. 2004. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430(6996): 218-222. Yamamoto, Y., Verma, U.N., Prajapati, S., Kwak, Y.T., and Gaynor, R.B. 2003. Histone H3 phosphorylation by IKK-[alpha] is critical for cytokine-induced gene expression. Nature 423: 655-659. Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S.T., Weil, R., and Agou, F. 1998. Cell 93: 1231-1240. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28581 | - |
dc.description.abstract | Nuclear factor - κB ( NFκB )是發炎與免疫反應的重要調控因子,亦連接發炎與癌症。NFκB 之活化主要經由IKK 磷酸化IκBα,導致其受分解, 進而使NFκB 進入核內活化下游之基因。IKKα 與IKKβ具高度結構之相似性, 在IKKα-/-與IKKβ-/-基因剔除的老鼠, 表現型( phenotype ) 之差異顯示兩者具有不同功能。IKKα可進入核內磷酸化Histone H 3 或CBP。本論文主要欲探討IKKα可調控哪些基因的表現, 因此利用SAGE ( Serial Analysis of Gene Expression )方式研究IKKwt 與IKKα-/- M E F 間基因的變化。我們取得2 3 0 0 0 個SAGE tag 並利用SAGE Genie 網站分析,有1 3 5 個基因具顯著差異。由RT-PCR 確認1 5 個基因, 8 0 % 符合SAGE 之結果; 部分基因亦受p65 或IKKγ 之調控。在分析過程中, 我們也找到一個未知基因之表現受IKK α 調控。進一步利用IPA ( Ingenuity Pathway Analysis )網站分析整體基因的變化, 比對這些基因與細胞功能或疾病的關係, 我們推測IKKα-/-會減少骨骼發育相關基因之表現, 並期盼能藉由研究這些基因之變化與IKKα 的關係,找出與疾病相關的治療方針。 | zh_TW |
dc.description.abstract | NFκB acts as a central coordinator of immune and inflammatory responses. It is also a crucial mediator of inflammation-induced tumor growth and progression. NFκB activation depends on phosphorylation-induced proteolysis of the inhibitory IκB, which is mediated by IKK and allows NFκB to translocate to the nucleus and activate target genes. Although similarity exists between IKKα and IKKβ, gene knockout studies clearly demonstrate that IKKα and IKKβ are functionally different.IKKα has been found to regulate many signaling pathway independently of direct regulation of NFκB, for example the phosphorylation of Histone H3 and CBP. In this thesis, I attempt to investigate the gene expression profiles regulated by IKKα.
Therefore, SAGE was performed to compare gene profiles between IKKwt and IKKα-/- MEF cells. We collected 23000 SAGE tags and analyzed by SAGE Genie website. 135 genes with significant differences between two pools of SAGE libraries were distinguished. Checking fifteen SAGE genes by RT-PCR, 80% match of the alteration was confirmed. Some genes were also regulated by p65 and IKKγ. We also detected a novel antisense-transcript which was up-regulated in IKKα-/- MEF.IPA (ingénuity pathway analysis) was used to correlate the expression profiles with functions. The results showed IKKα is probably related to skeletal development. We hope that new therapeutic targets can be identified by elucidating the relationship between IKKα and these networks. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T00:12:56Z (GMT). No. of bitstreams: 1 ntu-96-R94443023-1.pdf: 3890644 bytes, checksum: 05d3e776c7ac3f88e6eb07f0b0cd2265 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 縮寫表…………………………………………………………………1
中文摘要………………………………………………………………4 英文摘要………………………………………………………………6 緒論……………………………………………………………………8 實驗材料與方法………………………………………………………26 結果……………………………………………………………………43 討論……………………………………………………………………62 參考文獻………………………………………………………………68 | |
dc.language.iso | zh-TW | |
dc.title | 利用 SAGE 方法探討 IKKα 所調控基因之表現 | zh_TW |
dc.title | Exploration of the IKKα-regulated Genes by SAGE | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄭安理(ANN-LII CHENG),吳明賢(MING-SHIANG WU) | |
dc.subject.keyword | IKKα,SAGE, | zh_TW |
dc.relation.page | 76 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-28 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 3.8 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。